Diagnostic News and Research

RSS

Duke University Medical Center, LabCorp form joint venture to commercialize new biomarkers

Duke University Medical Center and Laboratory Corporation of America Holdings announced today the formation of a joint venture to commercialize new biomarkers. The new entity is designed to speed the translation of newly discovered biomarkers into widely available clinical tools that can measure individual therapeutic responses, predict disease progression, and evaluate any number of biologic or disease-causing processes.

21 Apr 2010

Diagnosis of gastric adenomyoma remains a challenging issue

Gastric adenomyoma (AM) is a rare, benign tumor, characteristically composed of glands and cysts, lined by columnar, flattened epithelia and a prominent smooth muscle stroma. Patients with gastric AM may be asymptomatic, or present as nonspecific gastrointestinal symptoms.

21 Apr 2010

3M Littmann Model 3200 and Zargis Cardioscan software receive red dot design award

3M and Zargis Medical Corp., today announced that the 3M Littmann Electronic Stethoscope Model 3200 and the Zargis Cardioscan software recently received two industry awards for design and innovation: the "red dot: best of the best" award for product design, given by the Design Zentrum Nordrhein Westfalen, an internationally known design institution located in Essen, Germany, and the Medical Design Excellence Award, sponsored by Medical Device & Diagnostic Industry magazine.

21 Apr 2010

Biomagnetics Diagnostics obtains handheld IOBS unit to detect pathogens

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced it has received its first handheld integrated optical biosensor unit from Los Alamos National Security, LLC.

21 Apr 2010

Computerised diagnostic model outperforms clinical judgement for diagnosing children with febrile illness

A computerised diagnostic model outperforms clinical judgement for the diagnosis of fever in young children, and may improve early treatment, finds a study published on bmj.com today.

21 Apr 2010

Genetic dermatology tests merge with DermaGenoma

Pioneering genetic tests in key areas of dermatology today merged into one molecular dermatology research and development innovator called DermaGenoma, Inc.

21 Apr 2010

Investment report on Sequenom from MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Sequenom Inc. The report includes financial, comparative and investment analysis, and industry information you need to know to make an educated investment decision.

20 Apr 2010

Striking down breast cancer related gene patent may not impact industry, says New York attorney

The recent decision in a Federal District Court in New York to strike down a patent for the breast cancer related BRCA-1 gene may not have the broad impact on the technology industry it had originally been feared to, says a New York attorney.

20 Apr 2010

NanoString Technologies launches new miRNA assay kits

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced a unique new product for miRNA analysis that includes a multiplexed assay for profiling the human miRNA transcriptome in a single tube. The company introduced the new assay kit, which expands the applications for its nCounter® Analysis System, at the American Association for Cancer Research annual meeting.

From NanoString Technologies 20 Apr 2010

CombiMatrix announces operational restructuring plan

CombiMatrix Corporation announced today that it is implementing a restructuring plan to significantly reduce operating costs, increase the focus on the Company's diagnostic services business and transition senior management. After the restructuring, CombiMatrix will be focused on its diagnostics services business, including increasing utilization of its existing tests, expanding the test menu, increasing the number of customers and partners, and improving reimbursement for its testing services.

20 Apr 2010

Spacelabs Healthcare launches Ultraview DM3 vital signs monitor

Combining the simplistic performance of a spot-check monitor with the sophistication of continuous monitoring, Spacelabs Healthcare's Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.

20 Apr 2010

Laparoscopic sleeve gastrectomy receives health insurance coverage

The American Society for Metabolic and Bariatric Surgery (ASMBS) today announced its support of recent policy changes by Aetna Inc. and United Healthcare. The national health insurance giants will now cover laparoscopic sleeve gastrectomy, a newer method of bariatric surgery that is becoming increasingly popular as a treatment for morbid obesity.

19 Apr 2010

Study reveals increased risk for cancer among Latino populations

New findings from epidemiology and observational studies show an increased risk for cancer among Latino populations, but unique demographic characteristics suggest the problem may be worse than currently known.

19 Apr 2010

Enigma Diagnostics receives patent for amplification consumables

Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,659,096 with claims that cover the use of amplification consumables in several current real-time and end point PCR instruments.

19 Apr 2010

Enhancing drug residence time may help develop better diagnostic, therapeutic agents

Research conducted at the Stony Brook University Institute for Chemical Biology & Drug Discovery that enhances the time a drug remains bound to its target, or residence time, may prove to be an important step in developing better diagnostic and therapeutic agents based partly on longer drug residence time.

17 Apr 2010

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

The Translational Genomics Research Institute and Asuragen Inc. today announced a research agreement that could lead to ways of detecting cancer before it spreads.

17 Apr 2010

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.

17 Apr 2010

Ontario continues to have high quality laboratory testing and diagnostic systems: Lab MDs

April 18th-24th is National Medical Laboratory Professionals Week and Ontario's laboratory physicians want to emphasize that Ontario continues to have one of the safest, highest quality laboratory testing and diagnostic systems in the world.

17 Apr 2010

Role of race and health insurance status in breast cancer diagnosis and treatment

Researchers at The GW Cancer Institute, with funding from the National Cancer Institute, examined the effect of race and health insurance status on diagnostic and treatment delays over a 5-year period, with initial screenings going back 12 years, and found that race may play a larger role than previously thought when it comes to optimal diagnosis and treatment of black women with breast cancer.

17 Apr 2010

SNM continues to stress the need for Congress to implement long-term fix

On April 16, the President signed a bill granting temporary relief from looming cuts to Medicare reimbursement rates. Although a positive step, the medical community-along with millions of patients-continues to face significant threats to medical coverage for critical diagnostic imaging tests and therapeutics.

17 Apr 2010

Diagnostic News and Research

Duke University Medical Center, LabCorp form joint venture to commercialize new biomarkers

Diagnosis of gastric adenomyoma remains a challenging issue

3M Littmann Model 3200 and Zargis Cardioscan software receive red dot design award

Biomagnetics Diagnostics obtains handheld IOBS unit to detect pathogens

Computerised diagnostic model outperforms clinical judgement for diagnosing children with febrile illness

Genetic dermatology tests merge with DermaGenoma

Investment report on Sequenom from MicroStockProfit.com

Striking down breast cancer related gene patent may not impact industry, says New York attorney

NanoString Technologies launches new miRNA assay kits

CombiMatrix announces operational restructuring plan

Spacelabs Healthcare launches Ultraview DM3 vital signs monitor

Laparoscopic sleeve gastrectomy receives health insurance coverage

Study reveals increased risk for cancer among Latino populations

Enigma Diagnostics receives patent for amplification consumables

Enhancing drug residence time may help develop better diagnostic, therapeutic agents

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

Ocera Therapeutics presents data on prevalence of neurocognitive impairment in cirrhotic patients

Ontario continues to have high quality laboratory testing and diagnostic systems: Lab MDs

Role of race and health insurance status in breast cancer diagnosis and treatment

SNM continues to stress the need for Congress to implement long-term fix

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News